SCHEMBL15428461

SCHEMBL15428461

COC(=O)c1cc(NC(=O)c2nc(NC(=O)c3nc(NC(=O)OC(C)(C)C)cn3C)cn2C)cn1C

nearest known ligand 0.40

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.40
HDAC2 Q92769 2/20 0.40
HDAC8 Q9BY41 2/20 0.40
GSK3B P49841 1/20 0.37
DYRK1A Q13627 1/20 0.37
ERBB2 P04626 9/20 0.36
P2RY12 Q9H244 1/20 0.35
LEF1 Q9UJU2 1/20 0.33
ATR Q13535 1/20 0.33
RPS6KA2 Q15349 1/20 0.33
LCK P06239 1/20 0.32
NAMPT P43490 1/20 0.32
IRAK4 Q9NWZ3 1/20 0.32
P2RX3 P56373 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3938614 0.99 HDAC1 (0.40) HDAC1HDAC2HDAC8GSK3BDYRK1A
SCHEMBL4019734 0.97 HDAC1 (0.43) HDAC1HDAC2HDAC8GSK3BDYRK1A
SCHEMBL3934001 0.96 HDAC1 (0.42) HDAC1HDAC2HDAC8GSK3BDYRK1A
SCHEMBL3417244 0.96 HDAC1 (0.42) HDAC1HDAC2HDAC8GSK3BDYRK1A
SCHEMBL13879863 0.92 HDAC1 (0.37) HDAC1HDAC2HDAC8GSK3BDYRK1A
SCHEMBL19614861 0.89 ERBB2 (0.41) HDAC1HDAC2HDAC8GSK3BDYRK1A
SCHEMBL23745120 0.89 HDAC1 (0.55) HDAC1HDAC2HDAC8ERBB2
SCHEMBL3417370 0.88 HDAC1 (0.39) HDAC1HDAC2HDAC8GSK3BDYRK1A
SCHEMBL16710976 0.88 HDAC1 (0.39) HDAC1HDAC2HDAC8GSK3BDYRK1A
SCHEMBL17230049 0.87 CYP17A1 (0.40) HDAC1HDAC2HDAC8GSK3BDYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8637664-B2 Alkyl 4- [4- (5-oxo-2,3,5, 11a-tetrahydo-5H-pyrrolo [2, 1-c] [1,4] benzodiazepine-8-yloxy)-butyrylamino]-1H-pyrrole-2-carboxylate derivatives and related compounds for the treatment of a proliferative disease SPIROGEN SARL (CH) 2014-01-28 US disclosed